Rebrote de parotiditis en la era vacunal. Factores implicados en un brote en Navarra, 2006–2007

Medicina Clinica - Tập 133 - Trang 777-782 - 2009
Jesús Castilla1, Mirian Fernández Alonso2, Manuel García Cenoz1,3, Víctor Martínez Artola4, Melania Íñigo Pestaña2, Isabel Rodrigo5, Aurelio Barricarte1,3
1Instituto de Salud Pública de Navarra, Pamplona, España
2Servicio de Microbiología, Clínica Universidad de Navarra, Pamplona, España
3CIBER de Epidemiología y Salud Pública (CIBERESP), España
4Sección de Microbiología, Hospital Virgen del Camino, Pamplona, España
5Servicio de Medicina Preventiva, Hospital de Navarra, Pamplona, España

Tài liệu tham khảo

Hilleman, 1967, Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation, N Engl J Med, 276, 252, 10.1056/NEJM196702022760502 Sugg, 1968, Field evaluation of live virus mumps vaccine, J Pediatr, 72, 461, 10.1016/S0022-3476(68)80334-8 2007, Comentario epidemiológico de las enfermedades de declaración obligatoria y Sistema de información microbiológica. Año 2006, Bol Epidemiol Semanal, 15, 109 Peltola, 2000, Mumps and rubella eliminated from Finland, JAMA, 284, 2643, 10.1001/jama.284.20.2643 1998, Measles, mumps, and rubella – vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mums: Recommendations of Advisory Committee on Immunization Practices (ACIP), Morb Mortal Wkly Rep, 47, 1 Ong, 2005, Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population, J Infect, 51, 294, 10.1016/j.jinf.2004.10.001 Richard, 2003, Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: A case-cohort study, Eur J Epidemiol, 18, 569, 10.1023/A:1024698900332 Pons, 2000, Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy, Euro Surveill, 5, 80, 10.2807/esm.05.07.00014-en Savage, 2005, BMJ, 330, 1119, 10.1136/bmj.330.7500.1119 Sartorius, 2005, An outbreak of mumps in Sweden, February–April 2004, Euro Surveill, 10, 191, 10.2807/esm.10.09.00559-en Dayan, 2008, Recent resurgence of mumps in the United States, N Engl J Med, 358, 1580, 10.1056/NEJMoa0706589 2008 Reina, 2003, Comparison between indirect immunofluorescence assay and shell vial culture for detection of mumps virus from clinical samples, J Clin Microbiol, 41, 5186, 10.1128/JCM.41.11.5186-5187.2003 2001 Gerstel L, Lenglet A, García Cenoz M. Mumps outbreak in young adults following a village festival in the Navarra region, Spain, August 2006. Euro Surveill [revista electrónica] 2006;11:E061109.4. [consultado 08/09/2008] Disponible en: http://www.eurosurveillance.org/ew/2006/061109.asp#4 Sanz, 2008, Evolución de los casos de parotiditis confirmados serológicamente en la Comunidad de Madrid durante un período de 7 años (2000–2006), Med Clin (Barc), 130, 292, 10.1157/13116573 Cohen, 2007, Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England, Emerg Infect Dis, 13, 12, 10.3201/eid1301.060649 Nöjd, 2001, Mumps virus neutralizing antibodies do no protect against reinfection with a heterologous mumps virus genotype, Vaccine, 19, 1727, 10.1016/S0264-410X(00)00392-3 Hviid, 2008, Mumps, Lancet, 371, 932, 10.1016/S0140-6736(08)60419-5 Plotkin SA. Mumps vaccine. En: Plotkin SA, Orenstein WA, editores. Vaccines (4th ed.), Philadelphia: WB Saunders; 2004. p. 452.